e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Vect-Horus
Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals
February 03, 2026
From
Vect-Horus
Via
GlobeNewswire
Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders
July 10, 2025
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus appoints Philippe Masset to Board of Directors, in further strengthening of leadership
April 24, 2025
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus appoints Carole Imbert as Chief Financial Officer to further reinforce its executive management team
March 25, 2025
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors
January 28, 2025
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus Strengthens Board of Directors with Appointment of Jean-Christophe Dantonel as New Member
November 14, 2024
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
May 07, 2024
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors
April 22, 2024
From
Vect-Horus
Via
GlobeNewswire
Vect-Horus Enters Exclusive License Agreement with Ionis Pharmaceuticals to Advance Systemic Delivery of RNA-Targeted Medicines for Neurological Diseases
January 30, 2024
From
Vect-Horus
Via
Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Pr. Xavier Declèves
January 11, 2024
From
Vect-Horus
Via
Business Wire
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
October 30, 2023
From
Vect-Horus
Via
Business Wire
Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer
April 03, 2023
From
Vect-Horus
Via
Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Frédéric Matonti, a Leading Ophthalmology Specialist
May 10, 2022
From
Vect-Horus
Via
Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Dr. Julia Alterman
March 22, 2022
From
Vect-Horus
Via
Business Wire
Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme
July 08, 2021
From
Vect-Horus
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.